Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

Seres Therapeutics (MCRB) Return on Capital Employed (2016 - 2025)

Seres Therapeutics (MCRB) has disclosed Return on Capital Employed for 11 consecutive years, with 0.77% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 25.0% to 0.77% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.77% through Dec 2025, up 25.0% year-over-year, with the annual reading at 0.79% for FY2025, 20.0% down from the prior year.
  • Return on Capital Employed hit 0.77% in Q4 2025 for Seres Therapeutics, up from 0.85% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.14% in Q3 2021 to a low of 1.08% in Q3 2022.
  • Historically, Return on Capital Employed has averaged 0.59% across 5 years, with a median of 0.61% in 2021.
  • Biggest five-year swings in Return on Capital Employed: crashed -94bps in 2022 and later surged 86bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.22% in 2021, then plummeted by -234bps to 0.74% in 2022, then surged by 47bps to 0.39% in 2023, then crashed by -165bps to 1.03% in 2024, then grew by 25bps to 0.77% in 2025.
  • Business Quant data shows Return on Capital Employed for MCRB at 0.77% in Q4 2025, 0.85% in Q3 2025, and 0.89% in Q2 2025.